IMO in the long run, IPIX shareholders would benef
Post# of 72445
(Total Views: 584)
Posted On: 06/09/2019 3:32:57 PM
Re: aragon1959 #57362
IMO in the long run, IPIX shareholders would benefit the most if the remaining assets were developed to FDA stage late 2 or 3 before partnering.
This would require a successful financial deal for Brilacidin OM and IBD.to finance the remaining drugs.
The remaining assets include the remaining Brilacidin indications which should be low cost quick trials and Kevetrin whose trials will be longer and more expensive.
That being said IPIXS's largest shareholders are older; Mrs Ehrlich, Menon and Aruda may want to cash out if they got the right deal.
JMO Farrell
"... that BP can acquire IPIX and its entire asset(s) with multi-billion $ mega deal do you agree that such option exists ???
Just sharing my thoughts
aragon "
This would require a successful financial deal for Brilacidin OM and IBD.to finance the remaining drugs.
The remaining assets include the remaining Brilacidin indications which should be low cost quick trials and Kevetrin whose trials will be longer and more expensive.
That being said IPIXS's largest shareholders are older; Mrs Ehrlich, Menon and Aruda may want to cash out if they got the right deal.
JMO Farrell
"... that BP can acquire IPIX and its entire asset(s) with multi-billion $ mega deal do you agree that such option exists ???
Just sharing my thoughts
aragon "
(2)
(0)